Results 101 to 110 of about 53,357 (145)

Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies. [PDF]

Front Immunol
Meng J, Lyu H, Wang Z, Bai X, Zhu H, Pu Y, He X, Xiao X, Zhao M.   +8 more
europepmc   +1 more source

Subacute sclerosing panencephalitis in a child six years after measles infection. [PDF]

IDCases
Le Feur L, Henry S, Jeziorski E, Dina J, Piarroux J, Meyer P, Foulongne V.   +6 more
europepmc   +1 more source

Mechanism of BMSCs Inhibiting Microglia Activation and Neuroinflammatory Response to Alleviate BCP by Regulating TLR4/ NF-κB Signaling Pathway. [PDF]

J Inflamm Res
Wang L, Rong Y, Li Y, Ren P, Yang H, Liu Y, Zhang J, Wu P, Wen Q.   +8 more
europepmc   +1 more source

Facing the challenge of effective dosing, safety, and timing of intrathecal gene therapy for neurological disorders. [PDF]

EBioMedicine
Kagiava A, Kleopa KA.
europepmc   +1 more source

Intrathecal pemetrexed in patients with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) resistant refractory leptomeningeal metastasis lung adenocarcinoma: a retrospective study. [PDF]

J Thorac Dis
Yao R, Lin H, Li J, Ge M, Liang X, Zhou X.   +5 more
europepmc   +1 more source

Pathophysiology and treatment of leptomeningeal metastases in lung cancer. [PDF]

Transl Lung Cancer Res
Hida T.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Intrathecal Pumps

Physical Medicine and Rehabilitation Clinics of North America, 2022
Intrathecal drug delivery systems are a well-established intervention for chronic pain. The localized delivery of analgesics allows for reduced side effect profiles and pain scores in patients with chronic pain. Given their proven benefits and the development of novel intrathecal medications, intrathecal drug delivery systems are being used earlier in ...
Tyler, Ericson, Priyanka, Singla, Lynn, Kohan   +2 more
openaire   +2 more sources